Loading clinical trials...
Loading clinical trials...
Discovery and Validation of Proteogenomic Biomarker Panels in a Prospective Serial Blood and Urine Monitoring Study of Liver Transplant Recipients - Transplant Proteogenomics
Conditions
Locations
6
United States
Mayo Clinic
Phoenix, Arizona, United States
Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States
Mount Sinai School of Medicine
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Baylor University Medical Center
Dallas, Texas, United States
Start Date
August 1, 2012
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
September 2, 2016
NCT07233096
NCT06717919
NCT06899867
NCT05237583
NCT06682325
NCT06890234
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions